PDCD1 and hypophysitis: IRAEs observed in patients treated with antibodies targeted at CTLA4 and PD-1 and the receptors of their ligands phenocopy the autoimmune manifestations of patients with IEIs of CTLA4 and PDCD1. There are differences in the spectrum of autoimmune manifestations between IEIs and IRAEs, such as hypophysitis.